4//SEC Filing
Bancel Stephane 4
Accession 0001127602-25-004871
CIK 0001682852other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 4:06 PM ET
Size
8.8 KB
Accession
0001127602-25-004871
Insider Transaction Report
Form 4
Moderna, Inc.MRNA
Bancel Stephane
DirectorChief Executive Officer
Transactions
- Tax Payment
Common Stock
2025-02-12$30.93/sh−6,400$197,952→ 5,493,897 total - Award
Common Stock
2025-02-12+13,233→ 5,500,297 total
Holdings
- 9,050,372(indirect: See Footnote)
Common Stock
- 6,564,880(indirect: See Footnote)
Common Stock
Footnotes (4)
- [F1]The reported transaction is the vesting of performance-based restricted stock units granted to the reporting person on March 1, 2022 (the "2022 PSUs").
- [F2]Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vesting of the 2022 PSUs.
- [F3]These shares are owned directly by Boston Biotech Ventures, LLC ("Boston Biotech"). The reporting person is the majority equity unit holder and the sole managing member of Boston Biotech. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.
- [F4]These shares are owned directly by OCHA LLC ("OCHA"). The reporting person is the majority equity unit holder and the sole managing member of OCHA. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.
Documents
Issuer
Moderna, Inc.
CIK 0001682852
Entity typeother
Related Parties
1- filerCIK 0001443340
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 4:06 PM ET
- Size
- 8.8 KB